Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Noncytotoxic differentiation treatment of renal cell cancer.

Negrotto S, Hu Z, Alcazar O, Ng KP, Triozzi P, Lindner D, Rini B, Saunthararajah Y.

Cancer Res. 2011 Feb 15;71(4):1431-41. doi: 10.1158/0008-5472.CAN-10-2422. Epub 2011 Feb 8.

PMID:
21303982
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.

Alcazar O, Achberger S, Aldrich W, Hu Z, Negrotto S, Saunthararajah Y, Triozzi P.

Int J Cancer. 2012 Jul 1;131(1):18-29. doi: 10.1002/ijc.26320. Epub 2011 Sep 6.

PMID:
21796622
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.

Ng KP, Ebrahem Q, Negrotto S, Mahfouz RZ, Link KA, Hu Z, Gu X, Advani A, Kalaycio M, Sobecks R, Sekeres M, Copelan E, Radivoyevitch T, Maciejewski J, Mulloy JC, Saunthararajah Y.

Leukemia. 2011 Nov;25(11):1739-50. doi: 10.1038/leu.2011.159. Epub 2011 Jun 24.

PMID:
21701495
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.

Inoue H, Kauffman M, Shacham S, Landesman Y, Yang J, Evans CP, Weiss RH.

J Urol. 2013 Jun;189(6):2317-26. doi: 10.1016/j.juro.2012.10.018. Epub 2012 Oct 16.

PMID:
23079374
[PubMed - indexed for MEDLINE]
5.

The emerging role of nuclear factor kappa B in renal cell carcinoma.

Morais C, Gobe G, Johnson DW, Healy H.

Int J Biochem Cell Biol. 2011 Nov;43(11):1537-49. doi: 10.1016/j.biocel.2011.08.003. Epub 2011 Aug 12. Review.

PMID:
21854869
[PubMed - indexed for MEDLINE]
6.

A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma.

Iwata H, Sato H, Suzuki R, Yamada R, Ichinomiya S, Yanagihara M, Okabe H, Sekine Y, Yano T, Ueno K.

Int J Oncol. 2011 Jun;38(6):1653-61. doi: 10.3892/ijo.2011.999. Epub 2011 Apr 6.

PMID:
21479360
[PubMed - indexed for MEDLINE]
7.

Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.

Morais C, Healy H, Johnson DW, Gobe G.

Nephrol Dial Transplant. 2010 May;25(5):1462-74. doi: 10.1093/ndt/gfp673. Epub 2009 Dec 27.

PMID:
20037166
[PubMed - indexed for MEDLINE]
Free Article
8.

Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.

Law CL, Gordon KA, Toki BE, Yamane AK, Hering MA, Cerveny CG, Petroziello JM, Ryan MC, Smith L, Simon R, Sauter G, Oflazoglu E, Doronina SO, Meyer DL, Francisco JA, Carter P, Senter PD, Copland JA, Wood CG, Wahl AF.

Cancer Res. 2006 Feb 15;66(4):2328-37.

PMID:
16489038
[PubMed - indexed for MEDLINE]
Free Article
9.

Antitumor effects of an imidazoquinoline in renal cell carcinoma.

Schwartz MJ, Liu H, Hwang DH, Kawamoto H, Scherr DS.

Urology. 2009 May;73(5):1156-62. doi: 10.1016/j.urology.2008.02.010. Epub 2009 Jan 1.

PMID:
19118885
[PubMed - indexed for MEDLINE]
10.

FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.

Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.

Anticancer Res. 2007 Jan-Feb;27(1A):75-88.

PMID:
17352219
[PubMed - indexed for MEDLINE]
Free Article
11.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R.

Int J Cancer. 2011 Apr 15;128(8):1793-803. doi: 10.1002/ijc.25507.

PMID:
20549706
[PubMed - indexed for MEDLINE]
12.

5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.

Shang D, Liu Y, Xu X, Han T, Tian Y.

Cancer Lett. 2011 Dec 8;311(2):230-6. doi: 10.1016/j.canlet.2011.08.012. Epub 2011 Aug 22.

PMID:
21880414
[PubMed - indexed for MEDLINE]
13.

ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma.

Carew JS, Esquivel JA 2nd, Espitia CM, Schultes CM, Mülbaier M, Lewis JD, Janssen B, Giles FJ, Nawrocki ST.

PLoS One. 2012;7(1):e31120. doi: 10.1371/journal.pone.0031120. Epub 2012 Jan 25.

PMID:
22295124
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.

Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC.

J Clin Oncol. 2006 Aug 10;24(23):3771-9. Epub 2006 Jun 26.

PMID:
16801630
[PubMed - indexed for MEDLINE]
Free Article
15.

2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Nagaprashantha LD, Vatsyayan R, Singhal J, Lelsani P, Prokai L, Awasthi S, Singhal SS.

Carcinogenesis. 2011 Apr;32(4):568-75. doi: 10.1093/carcin/bgr021. Epub 2011 Feb 8.

PMID:
21304051
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Hayakawa M, Sumitomo M, Asano T.

Br J Cancer. 2010 May 25;102(11):1592-9. doi: 10.1038/sj.bjc.6605691. Epub 2010 May 11.

PMID:
20461084
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.

Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ.

Cancer Res. 2003 Jun 1;63(11):2940-7.

PMID:
12782601
[PubMed - indexed for MEDLINE]
Free Article
18.

Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.

Hammers HJ, Verheul HM, Salumbides B, Sharma R, Rudek M, Jaspers J, Shah P, Ellis L, Shen L, Paesante S, Dykema K, Furge K, Teh BT, Netto G, Pili R.

Mol Cancer Ther. 2010 Jun;9(6):1525-35. doi: 10.1158/1535-7163.MCT-09-1106. Epub 2010 May 25.

PMID:
20501804
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.

Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.

Clin Cancer Res. 1998 Dec;4(12):2957-66.

PMID:
9865906
[PubMed - indexed for MEDLINE]
Free Article
20.

Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.

Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Müller M, Krammer P, Gabbert HE, Gerharz CD.

Br J Cancer. 2000 Jun;82(11):1851-9.

PMID:
10839301
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk